The following are my rough estimates based on the company announcements and some deductions:
Sales Revenue for the past 3 qtrs were = $199k 623k pepp tablets (pa) @ 40c (wholesale price) = $249k pepp sales have doubled in the past half year therefore the last qtr + this qtr should be $166k - as last qtr was only 85k in total sales revenue (& this contained bird flu test kits etc), then pepp sales should be at least $120k this qtr. 500k avian flu tests @ $5 = $2.5m
Therefore sales revenue this quarter of a minimum of $2.62m should be reported - assuming
1. the wholesale price for pepp tablets is approx 1/3 of the retail price 2. the sale price of the tests kits are $5 (I have assumed a discounted price due to the bulk order) 3. the company has received the full money from the 500k avian bird flu tests (if they haven't then I would be concerned that the terms of the sale agreement had not been met - and this will seriously affect the projected short term profitability)
So if the quarterly comes out with considerably less than $2.62m in sales revenue, I would be seriously concerned that the announcements made by the company were not accurate.
Any comments? Cheers KM
RBY Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
